[Funding alert] Dutch-based Amazec Photonics Secures €1.5 Million in Seed Funding

Speaking about photonics and the Netherlands, it's likely that you'll come across references to PhotonDelta, an ecosystem of photonic chip technology organizations and cross-border growth accelerator. Amazec's announcement today is no exception.

Read also - Copenhagen-based Pluto.markets Secures €2.4 Million in Funding

A number of unidentified private investors have also contributed to the €1.5 million seed round in addition to PhotonDelta. Although photonics—which uses light to operate microchips—makes waves in the field of quantum computing, lasers, and ever-faster bandwidth applications, as demonstrated by Amazec Photonics, the technology can also be applied to medical diagnosis.

The cardiovascular monitoring systems currently in use are frequently intricate, intrusive, and imprecise. Thermodilution is the de facto method used today to quantify cardiac output. It entails infusing a predefined volume of liquid upstream of the heart and using specialized catheters implanted into the patient to record temperature changes downstream.

Read also - Stockholm-based MANTLE Raises over €2.8 Million in Funding

In addition to causing discomfort to the patient, the approach has significant measurement variation, cannot be utilized reliably during routine examinations, and is a somewhat blunt tool for a precise procedure—not to mention the related expenditures.

The monitoring gadget is fully external, eliminating the need for catheter insertion and going beyond accuracy into the realm of human comfort.

Read also - Vilnius-based Axiology Secures €2 Million in Funding

Amazec CEO Pim Kat shared: “The number of people suffering from cardiovascular diseases has risen by 93 per cent over the past 25 years and now impacts an estimated 550 million patients worldwide. Many of these people will die or suffer poor health outcomes because the tools we have to diagnose them simply aren’t good enough. Our solution can make a real difference because, not only does it vastly improve the accuracy of testing for cardiovascular disease, it is also much less invasive and simpler to use. This will substantially reduce costs and open the door to many more people being tested much more regularly. With this funding round we will be able to build ten prototypes and undertake extensive clinical trials with the intention of producing and selling devices across the EU by 2028.”

The business claims that later this year, it will commence clinical trials at Eindhoven's Catharina Hospital, and that three more facilities would be added by 2025. with the intention of starting production on a large scale and selling throughout the EU in 2028.

Read also - Copenhagen-based Go Autonomous Secures €10 Million in Series A Round Funding

About Amazec Photonics

Amazec Photonics focuses on advancements in the medical field of photonics-based ultrasensitive temperature sensing. It is anticipated that integrated photonics technology would open up new avenues for treatment, diagnosis, and monitoring, significantly transforming the healthcare industry.

Read also - Helsinki-based Vapaus Secures €15 Million in a Debt Funding